Buspirone: A Possible Cause of Alopecia

[摘要] Buspirone, an azapirone that was approved by the United States Food and Drug Administration (FDA) in 1986 for the treatment of generalized anxiety disorder, is a mixed agonist/antagonist at both 5HT1A and DA2 receptor sites.1 Using the online resource, Clinical Psychopharmacology, we reviewed the potential side effects of buspirone, which commonly include dizziness, drowsiness, nausea, and headache—but no mention of hair loss or alopecia.1 Through a search of the PubMed and PsyclNFO databases, using the search terms, “buspirone,” “alopecia,” and “hair loss,” we encountered no independent case reports of this association, but a brief mention of this relationship in an article on various psychopharmacological agents and hair loss.2

[学科分类] 精神健康和精神病学